With New CEO, Agilent to Evaluate Biz Units; Are Investors Ignoring LSCA? | GenomeWeb

Agilent Technologies' former CEO Ned Barnholt recently told BioCommerce Week that his firm simply "measures things," Now, following Barnholt's departure at the end of February, the company will be redirecting those measurement skills toward its own operations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.